Alembic Pharmaceuticals Cash Flow Annual

Trade
BSE: 533573 | NSE: APLLTD | ISIN: INE901L01018 | Sector: Biotechnology & Drugs
848.10 -2.05 (-0.24%)Updated : 21 Apr 2025
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 631.83354.59620.111,368.08
Depreciation/ Depletion 272.67275.43286.78183.47
Non- Cash Items 14.20212.20136.25-82.30
Changesin Working Capital -115.49-118.26-490.79-5.87
Cashfrom Operating Activities 803.21723.96552.351,463.38
Capital Expenditures -327.47-443.41-425.64-659.51
Other Investing Cash Flow Items Total 6.86-4.1853.67-179.30
Cashfrom Investing Activities -320.61-447.59-371.97-838.81
Financing Cash Flow Items -49.39-48.17-51.97-933.52
Total Cash Dividends Paid -157.25-196.56-275.190.00
Issuance( Retirement)of Debt Net -231.23-17.23109.81-397.99
Cashfrom Financing Activities -437.87-261.96-217.35-597.43
Net Changein Cash 44.7314.40-36.9726.21
Cash Interest Paid 49.3749.7051.9272.94
Cash Taxes Paid 19.8560.70123.43245.44
period Length 12.0012.0012.0012.00
period Type ----
Foreign Exchange Effects --0.010.00-0.93
Issuance( Retirement)of Stock Net --0.00734.08
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,370.00+64.15(4.91%)
828.05+33.65(4.24%)
422.80-4.45 (-1.04%)
2,350.00-24.65 (-1.04%)